Generation of C-terminally truncated amyloid-beta peptides is dependent on gamma-secretase activity - PubMed (original) (raw)
Generation of C-terminally truncated amyloid-beta peptides is dependent on gamma-secretase activity
Dirk Beher et al. J Neurochem. 2002 Aug.
Free article
Abstract
Aberrant production of amyloid-beta peptides by processing of the beta-amyloid precursor protein leads to the formation of characteristic extracellular protein deposits which are thought to be the cause of Alzheimer's disease. Therefore, inhibiting the key enzymes responsible for amyloid-beta peptide generation, beta- and gamma-secretase may offer an opportunity to intervene with the progression of the disease. In human brain and cell culture systems a heterogeneous population of amyloid-beta peptides with various truncations is detected and at present, it is unclear how they are produced. We have used a combination of surface enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) and a specific inhibitor of gamma-secretase to investigate whether the production of all amyloid-beta peptide species requires the action of gamma-secretase. Using this approach, we demonstrate that the production of all truncated amyloid-beta peptides except those released by the action of the nonamyloidogenic alpha-secretase enzyme or potentially beta-site betaAPP cleaving enzyme 2 depends on gamma-secretase activity. This indicates that none of these peptides are generated by a separate enzyme entity and a specific inhibitor of the gamma-secretase enzyme should havethe potential to block the generation of all amyloidogenicpeptides. Furthermore in the presence of gamma-secretase inhibitors, the observation of increased cleavage of the membrane-bound betaAPP C-terminal fragment C99 by alpha-secretase suggests that during its trafficking C99 encounters compartments in which alpha-secretase activity resides.
Similar articles
- Amyloid precursor protein compartmentalization restricts beta-amyloid production: therapeutic targets based on BACE compartmentalization.
Gandhi S, Refolo LM, Sambamurti K. Gandhi S, et al. J Mol Neurosci. 2004;24(1):137-43. doi: 10.1385/JMN:24:1:137. J Mol Neurosci. 2004. PMID: 15314262 - Secretases as therapeutic targets for the treatment of Alzheimer's disease.
Dominguez DI, De Strooper B, Annaert W. Dominguez DI, et al. Amyloid. 2001 Jun;8(2):124-42. doi: 10.3109/13506120109007356. Amyloid. 2001. PMID: 11409035 Review. - The role of proteolysis in Alzheimer's disease.
Hooper NM, Trew AJ, Parkin ET, Turner AJ. Hooper NM, et al. Adv Exp Med Biol. 2000;477:379-90. doi: 10.1007/0-306-46826-3_39. Adv Exp Med Biol. 2000. PMID: 10849764 Review.
Cited by
- Differential effects between γ-secretase inhibitors and modulators on cognitive function in amyloid precursor protein-transgenic and nontransgenic mice.
Mitani Y, Yarimizu J, Saita K, Uchino H, Akashiba H, Shitaka Y, Ni K, Matsuoka N. Mitani Y, et al. J Neurosci. 2012 Feb 8;32(6):2037-50. doi: 10.1523/JNEUROSCI.4264-11.2012. J Neurosci. 2012. PMID: 22323718 Free PMC article. - Identification and quantification of amyloid beta-related peptides in human plasma using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Kaneko N, Yamamoto R, Sato TA, Tanaka K. Kaneko N, et al. Proc Jpn Acad Ser B Phys Biol Sci. 2014;90(3):104-17. doi: 10.2183/pjab.90.104. Proc Jpn Acad Ser B Phys Biol Sci. 2014. PMID: 24621957 Free PMC article. - Early-onset dysfunction of retrosplenial cortex precedes overt amyloid plaque formation in Tg2576 mice.
Poirier GL, Amin E, Good MA, Aggleton JP. Poirier GL, et al. Neuroscience. 2011 Feb 3;174:71-83. doi: 10.1016/j.neuroscience.2010.11.025. Epub 2010 Nov 18. Neuroscience. 2011. PMID: 21093545 Free PMC article. - γ-Secretase-Dependent Proteolysis of Transmembrane Domain of Amyloid Precursor Protein: Successive Tri- and Tetrapeptide Release in Amyloid β-Protein Production.
Takami M, Funamoto S. Takami M, et al. Int J Alzheimers Dis. 2012;2012:591392. doi: 10.1155/2012/591392. Epub 2012 Dec 31. Int J Alzheimers Dis. 2012. PMID: 23346458 Free PMC article. - Chemical Biology, Molecular Mechanism and Clinical Perspective of γ-Secretase Modulators in Alzheimer's Disease.
Bulic B, Ness J, Hahn S, Rennhack A, Jumpertz T, Weggen S. Bulic B, et al. Curr Neuropharmacol. 2011 Dec;9(4):598-622. doi: 10.2174/157015911798376352. Curr Neuropharmacol. 2011. PMID: 22798753 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical